Psoriasis Treatment Market: Global Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2017-2021 and Forecast 2022-2028

$ PRICE - $ 3,000.00$ 8,900.00

Psoriasis Treatment Market: By drug class (TNF Inhibitors, Vitamin D Analogues, Interleukin Blockers, Topical Corticosteroids, Monoclonal Antibodies, Other) By psoriasis type (Plaque Psoriasis, Guttate Psoriasis, Flexural Psoriasis, Inverse Psoriasis, Psoriatic Psoriasis), By route of administration (Oral,Topical, Parenteral), By distribution channel (Hospital Pharmacies, Retail Pharmacie, Online Pharmacies) – Geography

 

$ PRICE - $ 3,000.00$ 8,900.00
Clear selection
Clear
$ PRICE - $ 3,000.00$ 8,900.00
FacebookTwitterLinkedinEmail
SKU: N/A Categories: ,

Report

Description

Psoriasis Treatment Market size was valued at USD 42.72 billion in 2021 and is expected to grow at a CAGR of 9.5 % from 2022-2028. Psoriasis is a chronic autoimmune disease characterized by abnormal growth of the skin cells. It forms skin patches above the skin and it is not contagious. Psoriasis skin patches are red and itchy. There are different types of psoriasis namely guttate psoriasis, plaque psoriasis, pustular psoriasis, erythrodermic psoriasis and inverse psoriasis. Plaque psoriasis is common and constitutes about 90% of psoriasis cases. The diagnosis of psoriasis is typically made by obtaining information from the physical examination of the skin, medical history, and relevant family health history. Psoriasis affects skin over the elbows, knees, and scalp and is often itchy. Although any area may be involved, it tends to be more common at sites of friction, scratching, or abrasion. Currently, there was no cure for psoriasis. However, treatment is focused on curing the symptoms. Treatment may include steroid creams, vitamin D3 cream, UV light, and immunosuppressants. Psoriasis treatment market is expected to show significant growth rate owing to prevalence rates and severity of the disease. According to World Health Organization (WHO), 1.3%-34.7% of psoriasis patients develop chronic psoriatic arthritis, which may lead to joint deformations and disability. World Health Organization (WHO) also predicts that psoriasis affects about 100 million people with prevalence rates of 0.09% to 11.43% in different countries. The most common type of psoriasis is plaque psoriasis, affecting 90% of all psoriasis cases. Market players are focusing on R&D to develop new drugs and treatments for psoriasis. The market has a handful of drugs and dominated by generics and biologics. Market players heavily influencing the treatment decisions. Due to the entry of biosimilars into the market, there is availability of cheaper drugs to treat psoriasis and it leading to increased availability and increase market size. In addition, market has drug pipelines which are expected to boost the psoriasis treatment market during forecast period.

Key Developments:

In July 2017, Janssen Biotech, Inc.’s tremfya (guselkumab) approved by U.S. Food and Drug Administration (FDA) for the treatment of adults living with moderate to severe plaque psoriasis.

In February 2017, US Food and Drug Administration (FDA) approved siliq(brodalumab) injection for the treatment of adult patients with moderate-to-severe plaque psoriasis. This drug was developed by Valeant Pharmaceuticals by partnering with AstraZeneca.

 

Psoriasis Treatment Market

MARKET SUMMARY
-
9.5% CAGR
  • Study Period– 2022 – 2028
  • Base Year– 2021
  • CAGR– 9.5%
  • Largest Market– North America
  • Fastest Growing Market– Europe

Psoriasis Treatment Market

  • The report on global psoriasis treatment market gives historical, current, and future market sizes (US$ Bn) on the basis of drug class, type, route of administration, adistribution channel and geography.
  • The psoriasis treatment market report gives comprehensive outlook across the region with special emphasis on key regions such as North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
Market Key Players
  • Amgen Inc. (U.S)
  • Merck & Co., Inc. (U.S)
  • Pfizer, Inc. (U.S)
  • AstraZeneca (U.K)
  • AbbVie Inc. (U.S)
  • Biogen (U.S)
Psoriasis Treatment Market Dynamics

Global psoriasis treatment market is driven by increase in smoking and alcohol consumption trends globally. Increased spending on medicines and escalating health care expenditure are the key growth drivers of the market. Psoriasis treatment mainly treated by topical agents only. The recent launch of systemic products into the market expected to drive the growth of the market. However, high cost of the drugs and side-effects associated with the existing medication for psoriasis are expected to hinder the psoriasis treatment market during the forecast period.


North-America got significant share

Psoriasis Treatment Market

Geographically, global psoriasis treatment market has been segmented into following regions viz. North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. North America accounts largest market in the global psoriasis treatment market due to high prevalence of the disease. According to American Academy of Dermatology, approximately 7.5 Mn people in the United States have psoriasis. In Europe, the psoriasis treatment market is expected to grow at significant rate due to factors such as increased prevalence and growing awareness about skin diseases and recent launch of biosimilars such as elerzi, amzevita. In Asia-Pacific region, India and China are expected to be fastest growing market due to developing infrastructure and rapid growth in awareness and available treatment options for psoriasis.

Latin America
Latin-America
North-America
North-America
Europe
Europe
Asia Pacific
Asia-Pacific
Middle East
Middle East

Key

Features of the Report

  • The report provides granular level information about the market size, regional market share and forecast from 2022-2028
  • The report covers in-detail insights about the competitor’s overview, key findings and their key strategies
  • The report outlines drivers, restraints, challenges, and trends that are currently faced by the industry
  • The report tracks recent innovations, key developments and startup’s details that are working in the industry
  • The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
Segmentation

Psoriasis Treatment Market


Location

GEOGRAPHY

Frequently Asked Questions

The psoriasis treatment market is projected to expand at a CAGR of 9.5% during the forecast period

Amgen Inc. (U.S), Eli Lilly and Company(U.S), Novartis AG (Switzerland), Merck & Co., Inc. (U.S), Johnson & Johnson Services, Inc., (U.S), Pfizer, Inc. (U.S), AstraZeneca (U.K)

North America is the fastest-growing region for psoriasis treatment market


Report

Table Of Content

    1. Executive summary
    2. Global Psoriasis Treatment Market Introduction
      • Global Psoriasis Treatment Market– Taxonomy
      • Global Psoriasis Treatment Market–Definitions
        • Drug Class
        • Psoriasis Type
    1. Global Psoriasis Treatment Market Dynamics
      • Drivers
      • Restraints
      • Opportunities/Unmet Needs of the Market
      • Trends
      • Global Psoriasis Treatment Market Dynamics – Factors Impact Analysis
      • Global Psoriasis Treatment Market– Recent Market Introductions
    2. Global Psoriasis Treatment Market Analysis, 2019 – 2020 and Forecast, 2020 – 2026
      • Market Analysis, 2019 – 2020 and Forecast, 2020 – 2026 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%)
      • Market Oppurtunity Analysis
    3. Global Psoriasis Treatment Market Forecast, By Drug Class, 2019 – 2020 and Forecast, 2020 – 2026
      • TNF Inhibitors
        • Market Analysis, 2019 – 2020 and Forecast, 2020 – 2026 (Revenue, USD Mn)
        • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
        • Market Opportunity Analysis
      • Vitamin D Analogues
        • Market Analysis, 2019 – 2020 and Forecast, 2020 – 2026 (Revenue, USD Mn)
        • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
        • Market Opportunity Analysis
      • Interleukin Blockers
        • Market Analysis, 2019 – 2020 and Forecast, 2020 – 2026 (Revenue, USD Mn)
        • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
        • Market Opportunity Analysis
      • Topical Corticosteroids
        • Market Analysis, 2019 – 2020 and Forecast, 2020 – 2026 (Revenue, USD Mn)
        • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
        • Market Opportunity Analysis
      • Monoclonal Antibodies
        • Market Analysis, 2019 – 2020 and Forecast, 2020 – 2026 (Revenue, USD Mn)
        • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
        • Market Opportunity Analysis
      • Others
        • Market Analysis, 2019 – 2020 and Forecast, 2020 – 2026 (Revenue, USD Mn)
        • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
        • Market Opportunity Analysis
    1. Global Psoriasis Treatment Market Forecast, By Psoriasis Type, 2019 – 2020 and Forecast, 2020 – 2026
      • Plaque Psoriasis
        • Market Analysis, 2019 – 2020 and Forecast, 2020 – 2026 (Revenue, USD Mn)
        • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
        • Market Opportunity Analysis
      • Guttate Psoriasis
        • Market Analysis, 2019 – 2020 and Forecast, 2020 – 2026 (Revenue, USD Mn)
        • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
        • Market Opportunity Analysis
      • Flexural Psoriasis
        • Market Analysis, 2019 – 2020 and Forecast, 2020 – 2026 (Revenue, USD Mn)
        • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
        • Market Opportunity Analysis
      • Inverse Psoriasis
        • Market Analysis, 2019 – 2020 and Forecast, 2020 – 2026 (Revenue, USD Mn)
        • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
        • Market Opportunity Analysis
      • Psoriatic Psoriasis
        • Market Analysis, 2019 – 2020 and Forecast, 2020 – 2026 (Revenue, USD Mn)
        • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
        • Market Opportunity Analysis
    1. Global Psoriasis Treatment Market Forecast, By Route of Administration, 2019 – 2020 and Forecast, 2020 – 2026
      • Oral
        • Market Analysis, 2019 – 2020 and Forecast, 2020 – 2026 (Revenue, USD Mn)
        • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
        • Market Opportunity Analysis
      • Topical
        • Market Analysis, 2019 – 2020 and Forecast, 2020 – 2026 (Revenue, USD Mn)
        • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
        • Market Opportunity Analysis
      • Pareneteral
        • Market Analysis, 2019 – 2020 and Forecast, 2020 – 2026 (Revenue, USD Mn)
        • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
        • Market Opportunity Analysis
    1. Global Psoriasis Treatment Market Forecast, By Distribution Channel, 2019 – 2020 and Forecast, 2020 – 2026
      • Hospital Pharmacies
        • Market Analysis, 2019 – 2020 and Forecast, 2020 – 2026 (Revenue, USD Mn)
        • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
        • Market Opportunity Analysis
      • Retail Pharmacies
        • Market Analysis, 2019 – 2020 and Forecast, 2020 – 2026 (Revenue, USD Mn)
        • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
        • Market Opportunity Analysis
      • Online Pharmacies
        • Market Analysis, 2019 – 2020 and Forecast, 2020 – 2026 (Revenue, USD Mn)
        • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
        • Market Opportunity Analysis
    1. Global Psoriasis Treatment Market Forecast, By Region, 2019 – 2020 and Forecast, 2020 – 2026
      • North America
        • Market Analysis, 2019 – 2020 and Forecast, 2020 – 2026 (Revenue, USD Mn)
        • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
        • Market Opportunity Analysis
      • Europe
        • Market Analysis, 2019 – 2020 and Forecast, 2020 – 2026 (Revenue, USD Mn)
        • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
        • Market Opportunity Analysis
      • Asia-Pacific
        • Market Analysis, 2019 – 2020 and Forecast, 2020 – 2026 (Revenue, USD Mn)
        • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
        • Market Opportunity Analysis
      • Latin America
        • Market Analysis, 2019 – 2020 and Forecast, 2020 – 2026 (Revenue, USD Mn)
        • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
        • Market Opportunity Analysis
      • Middle East and Africa
        • Market Analysis, 2019 – 2020 and Forecast, 2020 – 2026 (Revenue, USD Mn)
        • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
        • Market Opportunity Analysis
      • Global Psoriasis Treatment Market- Opportunity Analysis Index – By Psoriasis Type, By Drug Class, By Route of Administration, By Distribution Channel, and Region, 2018 – 2024
    2. North America Psoriasis Treatment Market Analysis, 2019 – 2020 and Forecast, 2020 – 2026
      • Drug Class Analysis (2015 – 2019) and Forecast (2020 – 2026) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
        • TNF Inhibitors
        • Vitamin D Analogues
        • Interleukin Blockers
        • Topical Corticosteroids
        • Monoclonal Antibodies
        • Others
      • Psoriasis Type Analysis (2015 – 2019) and Forecast (2020 – 2026) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
        • Plaque Psoriasis
        • Guttate Psoriasis
        • Flexural Psoriasis
        • Inverse Psoriasis
        • Psoriatic Psoriasis
      • Route of Administration Analysis (2015 – 2019) and Forecast (2020 – 2026) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
        • Oral
        • Topical
        • Parenteral
      • Distribution Channel Analysis (2015 – 2019) and Forecast (2020 – 2026) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
        • Hospital Pharmacies
        • Retail Pharmacies
        • Online Pharmacies
      • Country Analysis (2015 – 2019) and Forecast (2020 – 2026) by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
        • S.
        • Canada
      • North America Psoriasis Treatment Market- Opportunity Analysis Index – By Psoriasis Type, By Drug Class, By Route of Administration, By Distribution Channel, and Country, 2018 – 2024
      • North America Psoriasis Treatment Market Dynamics – Trends
    3. Europe Psoriasis Treatment Market Analysis, 2019 – 2020 and Forecast, 2020 – 2026
      • Drug Class Analysis (2015 – 2019) and Forecast (2020 – 2026) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
        • TNF Inhibitors
        • Vitamin D Analogues
        • Interleukin Blockers
        • Topical Corticosteroids
        • Monoclonal Antibodies
        • Others
      • Psoriasis Type Analysis (2015 – 2019) and Forecast (2020 – 2026) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
        • Plaque Psoriasis
        • Guttate Psoriasis
        • Flexural Psoriasis
        • Inverse Psoriasis
        • Psoriatic Psoriasis
      • Route of Administration Analysis (2015 – 2019) and Forecast (2020 – 2026) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
        • Oral
        • Topical
        • Parenteral
      • Distribution Channel Analysis (2015 – 2019) and Forecast (2020 – 2026) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
        • Hospital Pharmacies
        • Retail Pharmacies
        • Online Pharmacies
      • Country Analysis (2015 – 2019) and Forecast (2020 – 2026) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
        • Germany
        • UK
        • France
        • Spain
        • Italy
        • Russia
        • Poland
        • Rest of Europe
      • Europe Psoriasis Treatment Market- Opportunity Analysis Index – By Psoriasis Type, By Drug Class, By Route of Administration, By Distribution Channel, and Country, 2018 – 2024
      • Europe Psoriasis Treatment Market Dynamics – Trends
    4. Asia-Pacific Psoriasis Treatment Market Analysis, 2019 – 2020 and Forecast, 2020 – 2026
      • Drug Class Analysis (2015 – 2019) and Forecast (2020 – 2026) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
        • TNF Inhibitors
        • Vitamin D Analogues
        • Interleukin Blockers
        • Topical Corticosteroids
        • Monoclonal Antibodies
        • Others
      • Psoriasis Type Analysis (2015 – 2019) and Forecast (2020 – 2026) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
        • Plaque Psoriasis
        • Guttate Psoriasis
        • Flexural Psoriasis
        • Inverse Psoriasis
        • Psoriatic Psoriasis
      • Route of Administration Analysis (2015 – 2019) and Forecast (2020 – 2026) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
        • Oral
        • Topical
        • Parenteral
      • Distribution Channel Analysis (2015 – 2019) and Forecast (2020 – 2026) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
        • Hospital Pharmacies
        • Retail Pharmacies
        • Online Pharmacies
      • Country Analysis (2015 – 2019) and Forecast (2020 – 2026) by Revenue (USD Mn),
    5. Y-o-Y Growth (%), and Market Share (%)
      • Japan
      • China
      • India
      • ASEAN
      • Australia & New Zealand
      • Rest of Asia-Pacific
    • Asia-Pacific Psoriasis Treatment Market- Opportunity Analysis Index – By Psoriasis Type, By Drug Class, By Route of Administration, By Distribution Channel, and Country, 2018 – 2024
    • Asia-Pacific Psoriasis Treatment Market Dynamics – Trends
    1. Latin America Psoriasis Treatment Market Analysis, 2019 – 2020 and Forecast, 2020 – 2026
      • Drug Class Analysis (2015 – 2019) and Forecast (2020 – 2026) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
        • TNF Inhibitors
        • Vitamin D Analogues
        • Interleukin Blockers
        • Topical Corticosteroids
        • Monoclonal Antibodies
        • Others
      • Psoriasis Type Analysis (2015 – 2019) and Forecast (2020 – 2026) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
        • Plaque Psoriasis
        • Guttate Psoriasis
        • Flexural Psoriasis
        • Inverse Psoriasis
        • Psoriatic Psoriasis
      • Route of Administration Analysis (2015 – 2019) and Forecast (2020 – 2026) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
        • Oral
        • Topical
        • Parenteral
      • Distribution Channel Analysis (2015 – 2019) and Forecast (2020 – 2026) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
        • Hospital Pharmacies
        • Retail Pharmacies
        • Online Pharmacies
      • Country Analysis (2015 – 2019) and Forecast (2020 – 2026) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
        • Brazil
        • Mexico
        • Argentina
        • Venezuela
        • Rest of Latin America
      • Latin America Psoriasis Treatment Market- Opportunity Analysis Index – By Psoriasis Type, By Drug Class, By Route of Administration, By Distribution Channel, and Country, 2018 – 2024
      • Latin America Psoriasis Treatment Market Dynamics – Trends
    2. Middle East & Africa Psoriasis Treatment Market Analysis, 2019 – 2020 and Forecast, 2020 – 2026
      • Drug Class Analysis (2015 – 2019) and Forecast (2020 – 2026) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
        • TNF Inhibitors
        • Vitamin D Analogues
        • Interleukin Blockers
        • Topical Corticosteroids
        • Monoclonal Antibodies
        • Others
      • Psoriasis Type Analysis (2015 – 2019) and Forecast (2020 – 2026) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
        • Plaque Psoriasis
        • Guttate Psoriasis
        • Flexural Psoriasis
        • Inverse Psoriasis
        • Psoriatic Psoriasis
      • Route of Administration Analysis (2015 – 2019) and Forecast (2020 – 2026) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
        • Oral
        • Topical
        • Parenteral
      • Distribution Channel Analysis (2015 – 2019) and Forecast (2020 – 2026) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
        • Hospital Pharmacies
        • Retail Pharmacies
        • Online Pharmacies
      • Country Analysis (2015 – 2019) and Forecast (2020 – 2026) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
        • Gulf Cooperation Council (GCC) Countries
        • Israel
        • South Africa
        • Rest of MEA
      • MEA Psoriasis Treatment Market- Opportunity Analysis Index – By Psoriasis Type, By Drug Class, By Route of Administration, By Distribution Channel, and Country, 2018 – 2024
      • MEA Psoriasis Treatment Market Dynamics – Trends
    3. Competition Landscape
      • Strategic Dashboard of Top Market Players
      • Company Profiles (Introduction, Financial Analysis, Drug & Service Offerings, Key Developments, Strategies, and SWOT Analysis)
        • Amgen Inc. (U.S)
        • Eli Lilly and Company(U.S)
        • Novartis AG (Switzerland)
        • Merck & Co., Inc. (U.S)
        • Johnson & Johnson Services, Inc., (U.S)
        • Pfizer, Inc. (U.S)
        • AstraZeneca (U.K)
        • AbbVie Inc. (U.S)
        • LEO Pharma A/S (Denmark)
        • Biogen (U.S)
    4. Research Methodology
    5. Key Assumptions and Acronyms

     


Report

Company Profile

  • Amgen Inc. (U.S)
  • Eli Lilly and Company(U.S)
  • Novartis AG (Switzerland)
  • Merck & Co., Inc. (U.S)
  • Johnson & Johnson Services, Inc., (U.S)
  • Pfizer, Inc. (U.S)
  • AstraZeneca (U.K)
  • AbbVie Inc. (U.S)
  • LEO Pharma A/S (Denmark)
  • Biogen (U.S)

Description

Psoriasis Treatment Market size was valued at USD 42.72 billion in 2021 and is expected to grow at a CAGR of 9.5 % from 2022-2028. Psoriasis is a chronic autoimmune disease characterized by abnormal growth of the skin cells. It forms skin patches above the skin and it is not contagious. Psoriasis skin patches are red and itchy. There are different types of psoriasis namely guttate psoriasis, plaque psoriasis, pustular psoriasis, erythrodermic psoriasis and inverse psoriasis. Plaque psoriasis is common and constitutes about 90% of psoriasis cases. The diagnosis of psoriasis is typically made by obtaining information from the physical examination of the skin, medical history, and relevant family health history. Psoriasis affects skin over the elbows, knees, and scalp and is often itchy. Although any area may be involved, it tends to be more common at sites of friction, scratching, or abrasion. Currently, there was no cure for psoriasis. However, treatment is focused on curing the symptoms. Treatment may include steroid creams, vitamin D3 cream, UV light, and immunosuppressants. Psoriasis treatment market is expected to show significant growth rate owing to prevalence rates and severity of the disease. According to World Health Organization (WHO), 1.3%-34.7% of psoriasis patients develop chronic psoriatic arthritis, which may lead to joint deformations and disability. World Health Organization (WHO) also predicts that psoriasis affects about 100 million people with prevalence rates of 0.09% to 11.43% in different countries. The most common type of psoriasis is plaque psoriasis, affecting 90% of all psoriasis cases. Market players are focusing on R&D to develop new drugs and treatments for psoriasis. The market has a handful of drugs and dominated by generics and biologics. Market players heavily influencing the treatment decisions. Due to the entry of biosimilars into the market, there is availability of cheaper drugs to treat psoriasis and it leading to increased availability and increase market size. In addition, market has drug pipelines which are expected to boost the psoriasis treatment market during forecast period.

Key Developments:

In July 2017, Janssen Biotech, Inc.’s tremfya (guselkumab) approved by U.S. Food and Drug Administration (FDA) for the treatment of adults living with moderate to severe plaque psoriasis.

In February 2017, US Food and Drug Administration (FDA) approved siliq(brodalumab) injection for the treatment of adult patients with moderate-to-severe plaque psoriasis. This drug was developed by Valeant Pharmaceuticals by partnering with AstraZeneca.

 

ASIA PACIFIC OFFICE

Precision Business Insights, 5th Floor, Mohan’s Elite, Opp : Bharat Petroleum Pump, Khanamet Road, Hitech City, Hyderabad – 500084

EUROPE OFFICE

Precision Business Insights, Kemp House, 152 – 160 City Road, London EC1V 2NX